{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:37:25Z","timestamp":1789011445668,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["U54-AI082973"],"award-info":[{"award-number":["U54-AI082973"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s10875-022-01261-1","type":"journal-article","created":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T14:03:12Z","timestamp":1650549792000},"page":"1026-1035","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Granulocyte Transfusions in Patients with Chronic Granulomatous Disease Undergoing Hematopoietic Cell Transplantation or Gene Therapy"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7501-806X","authenticated-orcid":false,"given":"Danielle E.","family":"Arnold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Chellapandian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhag","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanwaldeep","family":"Mallhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Heimall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Chitty-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Murguia-Favela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Gennery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Boulad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Arbuckle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morton J.","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Dvorak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda M.","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald B.","family":"Kohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi D.","family":"Notarangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Yun","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Puck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Pulsipher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy","family":"Torgerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry L.","family":"Malech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer W.","family":"Leiding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,21]]},"reference":[{"issue":"2","key":"1261_CR1","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.jaci.2017.02.026","volume":"140","author":"BE Marciano","year":"2017","unstructured":"Marciano BE, Allen ES, Cantilena CC, et al. Granulocyte transfusions in patients with chronic granulomatous disease and refractory infections: the NIH experience. J Allergy Clin Immunol. 2017;140(2):622\u20135.","journal-title":"J Allergy Clin Immunol"},{"key":"1261_CR2","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1046\/j.1537-2995.1996.36111297091747.x","volume":"36","author":"DF Stroncek","year":"1996","unstructured":"Stroncek DF, Leonard K, Eiber G, et al. Alloimmunization after granulocyte transfusions. Transfusion. 1996;36:1009\u201315.","journal-title":"Transfusion"},{"issue":"6","key":"1261_CR3","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/j.1537-2995.2010.02993.x","volume":"51","author":"KF Heim","year":"2011","unstructured":"Heim KF, Fleisher TA, Stroncek DF, et al. The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohort. Transfusion. 2011;51(6):1154\u201362.","journal-title":"Transfusion"},{"issue":"5","key":"1261_CR4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3109\/08880018.2013.868562","volume":"31","author":"R Diaz","year":"2014","unstructured":"Diaz R, Soundar E, Hartman SK, et al. Granulocyte transfusions for children with infection and neutropenia or granulocyte dysfunction. Pediatr Hematol Oncol. 2014;31(5):425\u201334.","journal-title":"Pediatr Hematol Oncol"},{"key":"1261_CR5","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/bmt.2015.53","volume":"50","author":"O Nikolajeva","year":"2015","unstructured":"Nikolajeva O, Mijovic A, Hess D, et al. Single-donor granulocyte transfusions for improving the outcome of high-risk pediatric patients with known bacterial and fungal infections undergoing stem cell transplantation: a 10-year single-center experience. Bone marrow transplant. 2015;50:846\u20139.","journal-title":"Bone marrow transplant"},{"issue":"2","key":"1261_CR6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/10428194.2019.1660977","volume":"61","author":"TM Nguyen","year":"2002","unstructured":"Nguyen TM, Scholl K, Idler I, et al. Granulocyte transfusions \u2013 bridging to allogeneic hematopoietic stem cell transplantation. Leuk Lymphoma. 2002;61(2):481\u20134.","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"1261_CR7","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1046\/j.1365-2141.2003.04583.x","volume":"123","author":"JP Kerr","year":"2003","unstructured":"Kerr JP, Liakopolou E, Brown J, et al. The use of stimulated granulocyte transfusions to prevent recurrence of past severe infections after allogeneic stem cell transplantation. Br J Haematol. 2003;123(1):114\u20138.","journal-title":"Br J Haematol"},{"key":"1261_CR8","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1046\/j.1537-2995.2002.00249.x","volume":"42","author":"K Hubel","year":"2002","unstructured":"Hubel K, Carter RA, Liles C, et al. Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors. Transfusion. 2002;42:1414\u201321.","journal-title":"Transfusion"},{"issue":"18","key":"1261_CR9","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1182\/blood-2015-05-645986","volume":"126","author":"TH Price","year":"2015","unstructured":"Price TH, Boeckh M, Harrison RW, et al. Efficacy of transfusion with granulocytes from G-CSF\/dexamethasone-treated donors in neutropenic patients with infection. Blood. 2015;126(18):2153\u201361.","journal-title":"Blood"},{"key":"1261_CR10","first-page":"CD005341","volume":"6","author":"LJ Estcourt","year":"2015","unstructured":"Estcourt LJ, Stanworth SJ, Doree C, et al. 2015 Granulocyte transfusions for preventing infections in people with neutropenia or neutrophil dysfunction. Cochrane Database Syst Rev. 2015;6:CD005341.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"1261_CR11","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1111\/trf.14551","volume":"58","author":"TH Price","year":"2018","unstructured":"Price TH, McCullough J, Strauss RG, et al. WBC alloimmunization: effects on the laboratory and clinical endpoints of therapeutic granulocyte transfusions. Transfusion. 2018;58(5):1280\u20138.","journal-title":"Transfusion"},{"key":"1261_CR12","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/sj.bmt.1702651","volume":"26","author":"B Bielori","year":"2000","unstructured":"Bielori B, Toren A, Wolach B, et al. Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation. Bone Marrow Transplant. 2000;26:1025\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"1261_CR13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/sj.bmt.1705233","volume":"37","author":"RF Sharon","year":"2006","unstructured":"Sharon RF, Bierings M, Vrielink H, et al. Pre-emptive granulocyte transfusions enable allogeneic hematopoietic stem cell transplantation in pediatric patients with chronic infections. Bone Marrow Transplant. 2006;37:331\u20133.","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"1261_CR14","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1182\/blood.V92.8.2719","volume":"92","author":"H Ozsahin","year":"1998","unstructured":"Ozsahin H, van Planta M, Muller I, et al. Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B. Blood. 1998;92(8):2719\u201324.","journal-title":"Blood"},{"issue":"12","key":"1261_CR15","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","volume":"15","author":"A Bacigalupo","year":"2009","unstructured":"Bacigalupo A, Ballen K, Rizzo D, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant. 2009;15(12):1628\u201333.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"1261_CR16","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus conference on acute GVHD grading. Bone marrow transplant. 1995;15(6):825\u20138.","journal-title":"Bone marrow transplant"},{"issue":"2","key":"1261_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1182\/blood.V57.2.267.267","volume":"57","author":"KM Sullivan","year":"1981","unstructured":"Sullivan KM, Shulman HM, Storb R, et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood. 1981;57(2):267\u201376.","journal-title":"Blood"},{"key":"1261_CR18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41591-019-0735-5","volume":"26","author":"DB Kohn","year":"2020","unstructured":"Kohn DB, Booth C, Kang EM, et al. Lentiviral gene therapy for X-linked chronic granulomatous diseae. Nat Med. 2020;26:200\u20136.","journal-title":"Nat Med"},{"issue":"10","key":"1261_CR19","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1182\/blood.2020005590","volume":"136","author":"R Chiesa","year":"2020","unstructured":"Chiesa R, Wang J, Blok HF, et al. Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults. Blood. 2020;136(10):1201\u201311.","journal-title":"Blood"},{"key":"1261_CR20","first-page":"1","volume":"00","author":"C Dedieu","year":"2020","unstructured":"Dedieu C, Albert MH, Mahlaoui N, et al. Outcome of chronic granulomatous disease \u2013 conventional treatment vs stem cell transplantation. Pediatr Allergy Immunol. 2020;00:1\u201310.","journal-title":"Pediatr Allergy Immunol"},{"key":"1261_CR21","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.3389\/fimmu.2020.01617","volume":"11","author":"M Yanagimachi","year":"2020","unstructured":"Yanagimachi M, Kato K, Iguchi A, et al. Hematopoietic cell transplantation for chronic granulomatous disease in Japan. Front Immunol. 2020;11:1617.","journal-title":"Front Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01261-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-022-01261-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01261-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T23:38:39Z","timestamp":1744155519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-022-01261-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,21]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["1261"],"URL":"https:\/\/doi.org\/10.1007\/s10875-022-01261-1","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,21]]},"assertion":[{"value":"21 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in accordance with site-specific Institutional Review Board\u2013approved protocols as well as the guidelines in the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"MCL is an employee and shareholder of Rocket Pharmaceuticals. FB is a scientific advisor for Elixirgen Therapeutics. MJC is on the scientific advisory board and has stock ownership for Homology Medicine; on the data and safety monitoring board for Bluebird Bio, Rocket Pharmaceuticals, and Chiesi Pharmaceutical; and an author for UpToDate. CCD perfoms consulting with Jazz Pharmaceuticals, Omeros Corporation, and Alexion Inc. JMP receives royalties from UpToDate and her spouse is employed by and holds stock in Invitae Inc. MAP receives honoraria or research funding from Mesoblast and Medexi, Miltenyi Biotec, Equillium Bio, Adaptive Biotechnologies, and Jasper Therapeutics and is on the advisory board of Equillium Bio. TT is a paid consultant for Horizon Pharmaceuticals. DBK is an inventor on intellectual property of the UC Reagents that they have licensed to ImmunoVec on lentiviral vectors and to Lyrik Therapeutics on gene editing. DBK is a member of the Scientific Advisory Boards and\/or ad hoc paid consultant to Allogene Therapeutics, Pluto Immunotherapeutics, ImmunoVec, Lyrik Therapeutics, MyoGene Bio, Bluebird Bio, and Sangamo Biosciences. JWL is an employee and shareholder of Bluebird Bio, a consultant and spearker for Horizon Therapeutics, consultant and speaker for Sobi, and on the advisory board for ADMA Biologics. The remaining authors have no relevant conflicts of interest to disclose. The content and opinions expressed are solely the responsibility of the authors and do not represent the official policy or position of the NIAID, ORDR, NCATS, NIH, or any other agency of the US Government.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}